Roflumilast Cream 0.15% in Patients with Atopic Dermatitis: Individual Patient Response from the Pooled INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials. J of Skin [Internet]. 2024 Mar. 18 [cited 2025 May 15];8(2):s372. Available from: https://skin.dermsquared.com/skin/article/view/2590